Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

Delayed Data
As of Nov 27
 +0.31 / +2.65%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 16.50, with a high estimate of 24.00 and a low estimate of 15.00. The median estimate represents a +37.27% increase from the last price of 12.02.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -18.12%
Growthannually -141.46%


Growthquarterly 64.58%
Growthannually -29.71%
Key to the earnings and sales forecast charts.